prednisolone has been researched along with Marchiafava-Bignami Disease in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Marchiafava-Bignami Disease: A neurodegenerative condition that is characterized by demyelination or necrosis of the CORPUS CALLOSUM. Symptoms include DEPRESSION; PARANOIA; DEMENTIA; SEIZURES; and ATAXIA which can progress to COMA and death in a few months. Marchiafava-Bignami syndrome is seen often in alcoholics but has been found in non-alcoholics as well.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, Y | 1 |
| Oishi, M | 1 |
| Ogawa, K | 1 |
| Kamei, S | 1 |
| Kashiwagi, Y | 1 |
| Horiuchi, T | 1 |
| Harashima, C | 1 |
| Matsubara, F | 1 |
| Harashima, S | 1 |
2 other studies available for prednisolone and Marchiafava-Bignami Disease
| Article | Year |
|---|---|
A patient with Marchiafava-Bignami disease as a complication of diabetes mellitus treated effectively with corticosteroid.
Topics: Adult; Anti-Inflammatory Agents; Corpus Callosum; Diabetes Complications; Female; Humans; Marchiafav | 2012 |
Marchiafava-Bignami disease-like lesions due to central nervous system lupus.
Topics: Administration, Oral; Adult; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Antibodies, An | 2010 |